Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;1(3):277-86.
doi: 10.3233/JPD-2011-11046.

Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease

Affiliations

Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease

Laura Parkkinen et al. J Parkinsons Dis. 2011.

Abstract

Progressive rostral spread of Lewy body (LB) pathology is thought to reflect the clinical course of Parkinson's disease (PD) although several studies have suggested that LBs are not the toxic species responsible for cell death. We investigated the relationship between nigral dopaminergic cell loss, distribution and density of α-synuclein-immunoreactive LBs and duration of motor symptoms in 97 patients with PD. Density of pigmented neurons was measured in a single section of one half of the substantia nigra (SN) with delineation of the dorsal and ventral tiers whereas the cortical and nigral LB densities were determined using a morphometric approach. The density of nigral neurons was estimated to decrease by 2% each year after confirmation of the clinical diagnosis of PD but showed marked heterogeneity with some PD patients with longer duration of illness still possessing a significant number of preserved pigmented nigral neurons at the time of death. An average 15% of surviving nigral neurones contained LBs and the age-adjusted proportion of LB-bearing neurons appeared relatively stable throughout the disease duration. No difference was observed in the age at death or duration of disease with respect to Braak PD stages. The nigral neuronal density was unrelated to either the Braak PD stage or to cortical LB densities. We conclude that nigral neuronal loss is slow and shows considerable variation in PD. Our data also provides no support for a primary pathogenic role of LBs as neither their distribution nor density was associated with the severity of nigral cell loss.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(a) Transverse level of the midbrain at the level of the 3rd cranial nerve showing how the two tiers of substantia nigra pars compacta (dorsal, SNCd and ventral, SNCv) were depicted (adapted from Halliday 2004). More ventrally positioned substantia nigra reticulata (SNR) and dorsolaterally located pars lateralis (SNpl) are also indicated. (b, c) Photomicrographs depicting the heterogeneity in the number of pigmented nigral neurons between two PD patients with similar disease duration. (b) PD patient with 27.5 year duration; nigral cell count 7.0/mm2, (c) PD patient with 27.0 year duration, nigral cell count 21.8/mm2. Arrows point to the 3rd nerve fascicles. Luxol fast blue/cresyl violet. Scale bars: 200 μm.
Fig. 2
Fig. 2
Graphs depicting correlations between duration of Parkinson’s disease and (a) the density and (b) log of the density of nigral pigmented neurons and (c) proportion of nigral neurons with Lewy bodies. D shows correlation between the number of Lewy bodies and the number of neurons in the substantia nigra.

References

    1. Goldberg MS, Lansbury PT., Jr Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson’s disease? Nat Cell Biol. 2000;2:E115–E119. - PubMed
    1. Caughey B, Lansbury PT. Protofibrils, pores, fibrils and neurodegeneration: Separating the responsible protein aggregates from innocent bystanders. Annu Rev Neurosci. 2003;26:267–298. - PubMed
    1. Volles MJ, Lansbury PT., Jr Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson’s disease. Biochemistry. 2003;42:7871–7878. - PubMed
    1. Kramer ML, Schulz-Schaeffer WJ. Presynaptic aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci. 2007;27:1405–1410. - PMC - PubMed
    1. Bodner RA, Outeiro TF, Altmann S, Maxwell MM, Cho SH, Hyman BT, McLean PJ, Young AB, Housman DE, Kazantsev AG. Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington’s and Parkinson’s diseases. Proc Natl Acad Sci USA. 2006;14:4246–4251. - PMC - PubMed

Publication types

Substances